@inbook{504654daa99c403d8b6876a12454c23a,
title = "Drugs Used in TB and Leprosy",
abstract = "Multidrug resistance continues to be a problem in the treatment of tuberculosis (TB). With more cases of multidrug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-TB), clinicians are reverting to second-line and third-line agents, which have proven to be more toxic in nature and costly. This chapter reviews the 2016 data on the side effect profiles of commonly used medications in Mycobacterium tuberculosis and Mycobacterium leprae infections. Medications covered in this chapter include bedaquiline, capreomycin, clofazamine, cycloserine, dapsone, delamanid, ethambutol, gatifloxacin, isoniazid, kanamycin, levofloxacin, moxifloxacin, pyrazinamide, and the rifamycins.",
keywords = "Adverse effects, Ethambutol, Isoniazid, Leprosy, Pyrazinamide, Rifamycins, Side effects, Tuberculosis",
author = "Ramanathan, {Meenakshi R.} and Sanders, {James M.}",
year = "2017",
doi = "10.1016/bs.seda.2017.06.025",
language = "English (US)",
series = "Side Effects of Drugs Annual",
publisher = "Elsevier B.V.",
pages = "283--293",
booktitle = "Side Effects of Drugs Annual",
}